Neostigmine metilsulfate with glycopyrronium bromide (Inj 2.5 mg with glycopyrronium bromide 0.5 mg per ml, 1 ml ampoule): Hospital supply issue resolved
Due to multiple shipping delays, the supplier expected a brief out of stock of neostigmine metilsulfate with glycopyrronium bromide (Pharmacode 2444097)
4 December 2024 | Update
Stock arrived early December. It will take another 1 to 2 weeks for the product to makes its way to pharmacies around the motu.
Affected product
Max Health, the supplier, advises that it's expecting a brief out of stock of this product because of a series of shipping delays.
Neostigmine metilsulfate with glycopyrronium bromide
- Inj 2.5 mg with glycopyrronium bromide 0.5 mg per ml, 1 ml ampoule
- Brand: Max Health
- Pharmacode: 2444097
- Price: $26.13
- Measure / Qty: per 10
Alternative product
Max Health has ordered a section 29 alternative, Novistig, which is due to arrive by Friday 1 November 2024. The product is registered in Australia and has the same excipients as the New Zealand registered product.
Novistig in the Australian register of therapeutic goods(external link)
The product will not be listed in the HML because the registered product is due back in stock by the end of November 2024.
Resupplied early December 2024
The supplier advises that stock arrived in early December 2024. It will take another 1 to 2 weeks for this product to make its way to pharmacies around the motu.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)